l.vukovic
TL2 Moderator · Utrecht
Contributes reviews on supplier material. Based in Utrecht.
Joined 12 March 2025 · last posted 15h
79 posts, newest first. Showing up to 150.
-
Follow-up: External review after an internal denial Replied, post #11 · Access › Insurance & coverage · 27 Jul 2026 · 0 likes I read post #9 twice before replying, because I had assumed the opposite. Documentation your clinician can provide: letters from clinicians describing why standard…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #20 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 31 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #109 · Compounds › Semaglutide · 17 Jul 2026 · 33 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #35 · Practice › Interactions · 12 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #14 · Clinical › Bloodwork · 8 Jul 2026 · 13 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
What a reversed-phase purity number actually is Replied, post #17 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 21 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #71 · Analytics › Method validation · 29 Jun 2026 · 4 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #14 · Access › International · 14 Jun 2026 · 27 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Does a peptide degrade silently, with no visual change? Replied, post #47 · Practice › Storage & stability · 13 Jun 2026 · 32 likes Worth separating two things that post #43 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #52 · Analytics › Home & field testing · 12 Jun 2026 · 0 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #76 · Evidence › Preprints · 11 Jun 2026 · 6 likes post #75 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #24 · Start Here › How to Ask · 7 Jun 2026 · 10 likes On post #20 — agreed on the reasoning, with one qualification. The specific question in the title is more useful than you might think. A title like "a question I have"…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #57 · Sourcing › Red flags · 5 Jun 2026 · 4 likes This follows post #54 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #57 · Sourcing › Red flags · 3 Jun 2026 · 2 likes post #56 is right about the mechanism and I think understates the practical bit. Exaggerated claims without documentation: every compound has limits. No peptide is…
-
Spreadsheets: an appreciation — what changed since Replied, post #59 · Lounge › Off topic · 2 Jun 2026 · 12 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
-
Blind submission and why it changes minds — the long version Replied, post #104 · Sourcing › Independent verification · 28 May 2026 · 14 likes Picking up post #101: that is the part I would want checked first. Repeat testing: if you want to verify the same lot a second time, testing with a different service…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #46 · Practice › Reconstitution · 10 May 2026 · 29 likes Worth separating two things that post #42 runs together. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #30 · Devices › Syringes & needles · 3 May 2026 · 0 likes Picking up post #27: that is the part I would want checked first. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or…
-
Constipation management, with a dietitian's contribution Replied, post #53 · Practice › Side effects · 15 Apr 2026 · 23 likes On post #49 — agreed on the reasoning, with one qualification. Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #51 · Sourcing › Vendor reports · 15 Apr 2026 · 4 likes I read post #49 twice before replying, because I had assumed the opposite. Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #77 · Research Methods › Statistics · 13 Apr 2026 · 1 like Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #91 · Clinical › Special populations · 30 Mar 2026 · 7 likes I read post #89 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Second pass at: What pooling buys you and what it destroys Replied, post #32 · Evidence › Meta-analyses · 29 Mar 2026 · 17 likes post #31 answers the question as asked. The question underneath it is different. Number needed to treat from a meta-analysis: can be computed from the pooled estimate…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #73 · Practice › Interactions · 26 Mar 2026 · 16 likes On post #69 — agreed on the reasoning, with one qualification. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #98 · Research Methods › N-of-1 designs · 24 Mar 2026 · 2 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #17 · Evidence › Journal club · 15 Mar 2026 · 11 likes This follows post #14 rather than contradicting it. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for…
-
Splitting an overlong document into two Replied, post #7 · Documentation › Wiki requests · 11 Mar 2026 · 0 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Why this subcategory is stricter about sourcing than most Replied, post #6 · Compounds › Secretagogues & GH axis · 7 Mar 2026 · 16 likes Coming back to post #4, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Comparing the STEP programme populations: who was actually enrolled Started this topic · Compounds › Semaglutide · 7 Mar 2026 · 9 likes Comparing the STEP programme populations: who was actually enrolled Writing it up because I had to work it out twice and would rather nobody else did. Comparing STEP 1…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #136 · Sourcing › Independent verification · 24 Feb 2026 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #20 · Start Here › Welcome · 10 Feb 2026 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Citation sweep results: how many references did not say what was claimed Replied, post #35 · Meta › Wiki maintenance · 24 Jan 2026 · 0 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #41 · Clinical › Special populations · 23 Jan 2026 · 2 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
[2026 update] What a purity-only report leaves out Replied, post #4 · Sourcing › Independent verification · 19 Jan 2026 · 4 likes post #2 answers the question as asked. The question underneath it is different. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #35 · Practice › Side effects · 14 Jan 2026 · 26 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
Reverse causation in a cohort study of weight and outcome Started this topic · Evidence › Study critique · 23 Dec 2025 · 12 likes On the subject in the title: Reverse causation in a cohort study of weight and outcome Working notes rather than a conclusion. Comparing SELECT ( N Engl J Med , 2023)…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #86 · Practice › Reconstitution · 25 Nov 2025 · 1 like Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #25 · Compounds › Tirzepatide · 9 Nov 2025 · 26 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Sleep quality changes during weight loss — what changed since Replied, post #50 · Wellbeing › Sleep · 4 Nov 2025 · 0 likes This follows post #47 rather than contradicting it. Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #25 · Compounds › Other compounds · 3 Nov 2025 · 33 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Sleep tracking data and its considerable limitations Replied, post #122 · Wellbeing › Sleep · 29 Oct 2025 · 26 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes.
-
Documentation that materially improves an appeal's chances Replied, post #24 · Access › Insurance & coverage · 10 Oct 2025 · 23 likes Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
-
Temperature loggers worth the money Replied, post #34 · Devices › Cold chain · 25 Sep 2025 · 16 likes Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate prepared solutions immediately after preparation. Most…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #82 · Practice › Side effects · 22 Sep 2025 · 5 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #89 · Evidence › Study critique · 15 Sep 2025 · 26 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #63 · Practice › Side effects · 15 Sep 2025 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #42 · Sourcing › Vendor reports · 18 Aug 2025 · 11 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Analytical identity of BPC-157: a 15-mer with a simple mass Replied, post #3 · Compounds › Repair & healing peptides · 17 Aug 2025 · 0 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #96 · Compounds › Retatrutide · 17 Aug 2025 · 13 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #8 · Practice › Storage & stability · 17 Jul 2025 · 7 likes post #7 is right about the mechanism and I think understates the practical bit. Published stability data applies specifically to the formulation studied, under the…
-
Research-use-only labelling: what it means and what it does not Replied, post #11 · Sourcing › Regulatory · 12 Jul 2025 · 3 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
High-resolution MS on aggregates and what it can see Replied, post #12 · Analytics › Mass spectrometry · 26 Jun 2025 · 2 likes Resolution: "high resolution" commonly means
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #51 · Compounds › Other compounds · 7 May 2025 · 14 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #87 · Devices › Cold chain · 18 Apr 2025 · 1 like Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #59 · Clinical › Comorbidities · 15 Apr 2025 · 27 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #79 · Practice › Reconstitution · 14 Apr 2025 · 5 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #5 · Sourcing › Vendor reports · 18 Mar 2025 · 7 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #120 · Pharmacology › Receptor biology · 18 Mar 2025 · 1 like I read post #118 twice before replying, because I had assumed the opposite. Species differences: rodent studies show the same compounds produce effects in rodents that…
-
Validating a method you did not develop — does this still hold? Replied, post #129 · Analytics › Method validation · 17 Mar 2025 · 11 likes Picking up post #126: that is the part I would want checked first. Specificity: the method can distinguish the intended compound from related impurities and degradation…
-
Charge states for a 4 kDa peptide, worked through Replied, post #116 · Analytics › Mass spectrometry · 15 Mar 2025 · 28 likes On post #112 — agreed on the reasoning, with one qualification. Resolution: "high resolution" commonly means
-
Consistent declarations and why they matter more than clever ones Replied, post #130 · Sourcing › Logistics · 5 Mar 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #32 · Compounds › Oral incretins · 25 Feb 2025 · 30 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #54 · Wellbeing › Mental health · 24 Feb 2025 · 1 like Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
Canadian access and provincial variation Replied, post #37 · Regional › North America · 31 Jan 2025 · 15 likes I read post #35 twice before replying, because I had assumed the opposite. Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #30 · Evidence › Journal club · 22 Jan 2025 · 13 likes This follows post #27 rather than contradicting it. Session format: read the paper before posting. The discussion is much better when everyone has. Start with the…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #11 · Compounds › Semaglutide · 17 Dec 2024 · 0 likes Coming back to post #9, because the follow-up matters more than the original answer. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent…
-
Coming back to: When to suspect the method rather than the sample Replied, post #21 · Analytics › Method validation · 3 Dec 2024 · 4 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #11 · Evidence › Journal club · 30 Nov 2024 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
EMA product information as a primary source — does this still hold? Replied, post #7 · Regional › European Union · 14 Nov 2024 · 0 likes Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with regional variation in specialist pathways. Private prescription is common.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #107 · Compounds › Other compounds · 10 Nov 2024 · 3 likes I read post #105 twice before replying, because I had assumed the opposite. This subcategory exists because some people will research compounds outside the main groups…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #154 · Clinical › Bloodwork · 29 Oct 2024 · 1 like Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #77 · Clinical › Prescriber conversations · 14 Oct 2024 · 11 likes Coming back to post #75, because the follow-up matters more than the original answer. Discussing off-label dosing: if you want to dose differently than the label…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #21 · Compounds › Other compounds · 28 Sep 2024 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: What consumer-accessible tests can and cannot determine Replied, post #9 · Analytics › Home & field testing · 27 Sep 2024 · 0 likes This follows post #6 rather than contradicting it. What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class…
-
Correlation in a self-tracked dataset: what it can support Replied, post #69 · Research Methods › Statistics · 23 Aug 2024 · 10 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #25 · Analytics › COA interpretation · 9 Aug 2024 · 0 likes I read post #23 twice before replying, because I had assumed the opposite. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent…
-
The most common factual error about semaglutide on the internet Replied, post #2 · Compounds › Semaglutide · 8 Jul 2024 · 12 likes Coming back to the opening post, because the follow-up matters more than the original answer. The mass figure differs between sources because of how the different…
-
Assessing a warm arrival: the decision process — one year on Replied, post #62 · Sourcing › Logistics · 30 May 2024 · 0 likes post #61 answers the question as asked. The question underneath it is different. Reshipment after seizure: if a parcel is seized, some suppliers will reship; others…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #9 · Practice › Dosing & titration · 30 May 2024 · 18 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…